Absci Corp. (ABSI)
10.16
+1.22
(+13.65%)
USD |
NASDAQ |
Oct 09, 16:00
10.13
-0.03
(-0.30%)
After-Hours: 20:00
Absci Cash from Operations (Quarterly) : -27.56M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.56M |
| March 31, 2026 | -26.31M |
| December 31, 2025 | -29.18M |
| September 30, 2025 | -25.03M |
| June 30, 2025 | -16.87M |
| March 31, 2025 | -21.84M |
| December 31, 2024 | -16.96M |
| September 30, 2024 | -20.73M |
| June 30, 2024 | -16.84M |
| March 31, 2024 | -17.86M |
| December 31, 2023 | -14.92M |
| September 30, 2023 | -10.36M |
| June 30, 2023 | -19.23M |
| Date | Value |
|---|---|
| March 31, 2023 | -20.12M |
| December 31, 2022 | -18.57M |
| September 30, 2022 | -19.04M |
| June 30, 2022 | -22.58M |
| March 31, 2022 | -21.15M |
| December 31, 2021 | -17.08M |
| September 30, 2021 | -21.75M |
| June 30, 2021 | -14.49M |
| March 31, 2021 | -7.285M |
| December 31, 2020 | -2.521M |
| September 30, 2020 | -2.708M |
| June 30, 2020 | -3.312M |
| March 31, 2020 | -2.429M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Twist Bioscience Corp. | 1.115M |
| Prime Medicine, Inc. | -41.05M |
| Beam Therapeutics, Inc. | -66.10M |
| Moderna, Inc. | -526.00M |
| Tenax Therapeutics, Inc. | -14.15M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 24.07M |
| Cash from Financing (Quarterly) | 102.73M |
| Free Cash Flow | -108.97M |
| Free Cash Flow Per Share (Quarterly) | -0.175 |
| Free Cash Flow to Equity (Quarterly) | -26.98M |
| Free Cash Flow to Firm (Quarterly) | -27.56M |
| Free Cash Flow Yield | -7.09% |